Related Experiment Videos
Immunophenotyping of acute leukaemias
1Laboratoire d'Immunologie du CHU, Faculté de Médecine, Université Henri Poincaré Nancy I, BP 184, 54500 Vandoeuvre les Nancy, France. bene@medecine.uhp-nancy.fr
Immunology Letters
|March 26, 2005
Summary
Immunophenotyping is crucial for acute leukaemia diagnosis and patient monitoring. This review details its current applications and future potential in understanding and managing these blood cancers.
Area of Science:
- Hematology
- Oncology
- Immunology
Background:
- Acute leukaemia requires thorough clinical and biological investigation for progress.
- Identifying prognostic factors and remission markers is essential for patient management.
- Immunophenotyping has become a key diagnostic tool in acute leukaemia over the last 25 years.
Purpose of the Study:
- To review the current state-of-the-art of immunophenotyping in acute leukaemias.
- To contextualize immunophenotyping within normal leukocyte maturation.
- To discuss established classifications, recommended panels, and clinical relevance.
Main Methods:
- Review of current literature on immunophenotyping in acute leukaemia.
- Analysis of established classifications and diagnostic panels.
- Discussion of key immunophenotypic features and their clinical significance.
Main Results:
- Immunophenotyping is a well-established method for acute leukaemia diagnosis.
- Specific immunophenotypic markers aid in prognosis and remission follow-up.
- Further improvements and applications of immunophenotyping are continually being explored.
Conclusions:
- Immunophenotyping plays a critical role in the diagnosis and management of acute leukaemias.
- Understanding leukocyte maturation provides context for interpreting immunophenotypic data.
- Emerging applications of immunophenotyping offer promise for future advancements in leukaemia research and patient care.